Healthcare provider profile · identity verified

Yanqing Gu, MD

Internal Medicine · MELBOURNE, FL · NPI 1841203528

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	512	40
Atorvastatin Calcium	Atorvastatin Calcium	443	92
Amlodipine Besylate	Amlodipine Besylate	400	84
Gabapentin	Gabapentin	357	56
Levothyroxine Sodium	Levothyroxine Sodium	350	59
Metoprolol Tartrate	Metoprolol Tartrate	285	55
Trazodone Hcl	Trazodone Hcl	261	43
Pantoprazole Sodium	Pantoprazole Sodium	258	48
Losartan Potassium	Losartan Potassium	207	34
Metformin Hcl	Metformin Hcl	195	33
Xarelto	Rivaroxaban	162	21
Divalproex Sodium	Divalproex Sodium	149	27
Hydralazine Hcl	Hydralazine Hcl	137	27
Memantine Hcl	Memantine Hcl	137	suppressed
Donepezil Hcl	Donepezil Hcl	133	22
Duloxetine Hcl	Duloxetine Hcl	129	22
Metoprolol Succinate	Metoprolol Succinate	122	21
Omeprazole	Omeprazole	121	28
Potassium Chloride	Potassium Chloride	119	22
Tamsulosin Hcl	Tamsulosin Hcl	119	21
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	118	suppressed
Lisinopril	Lisinopril	116	23
Doxycycline Hyclate	Doxycycline Hyclate	113	48
Furosemide	Furosemide	104	24
Rosuvastatin Calcium	Rosuvastatin Calcium	98	23
Sertraline Hcl	Sertraline Hcl	95	16
Finasteride	Finasteride	94	13
Levetiracetam	Levetiracetam	94	15
Escitalopram Oxalate	Escitalopram Oxalate	91	18
Ondansetron Hcl	Ondansetron Hcl	82	24
Pravastatin Sodium	Pravastatin Sodium	81	13
Bumetanide	Bumetanide	80	suppressed
Midodrine Hcl	Midodrine Hcl	80	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	12
Lokelma	Sodium Zirconium Cyclosilicate	73	suppressed
Alprazolam	Alprazolam	72	21
Allopurinol	Allopurinol	69	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	66	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Fluticasone Propionate	Fluticasone Propionate	58	17
Oxycodone Hcl	Oxycodone Hcl	58	suppressed
Clonidine Hcl	Clonidine Hcl	57	suppressed
Novolog Flexpen	Insulin Aspart	56	suppressed
Cephalexin	Cephalexin	54	31
Cefdinir	Cefdinir	53	37
Mirtazapine	Mirtazapine	51	14
Famotidine	Famotidine	49	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Tradjenta	Linagliptin	46	suppressed
Azithromycin	Azithromycin	45	29
Hydrochlorothiazide	Hydrochlorothiazide	44	suppressed
Carvedilol	Carvedilol	43	12
Clopidogrel	Clopidogrel Bisulfate	43	13
Albuterol Sulfate Hfa	Albuterol Sulfate	42	14
Montelukast Sodium	Montelukast Sodium	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	41	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	41	suppressed
Jardiance	Empagliflozin	41	suppressed
Latanoprost	Latanoprost	39	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	38	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	37	13
Nifedipine Er	Nifedipine	36	suppressed
Entresto	Sacubitril/Valsartan	35	suppressed
Prednisone	Prednisone	34	13
Methocarbamol	Methocarbamol	33	suppressed
Simvastatin	Simvastatin	33	suppressed
Ertapenem	Ertapenem Sodium	32	17
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Baclofen	Baclofen	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	28	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	28	suppressed
Lidocaine	Lidocaine	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	22
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Methylprednisolone	Methylprednisolone	26	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	26	suppressed
Sodium Chloride	0.9 % Sodium Chloride	26	11
Glimepiride	Glimepiride	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Scopolamine	Scopolamine	24	suppressed
Nystatin	Nystatin	23	12
Zenpep	Lipase/Protease/Amylase	23	suppressed
Insulin Aspart Flexpen	Insulin Aspart	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Glipizide	Glipizide	17	suppressed
Insulin Aspart	Insulin Aspart	17	suppressed
Lactulose	Lactulose	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Risperidone	Risperidone	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Atropine Sulfate	Atropine Sulfate	16	suppressed
Budesonide	Budesonide	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	16	suppressed
Linzess	Linaclotide	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Cyclosporine	Cyclosporine	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Valsartan	Valsartan	14	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Estradiol	Estradiol	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clonidine	Clonidine	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Voriconazole	Voriconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error